News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Brödernas Group AB (publ) delays the publication of the annual audited consolidated financial statements of the Group due in April 2025
Brödernas Group AB (publ) delays the publication of the annual audited consolidated financial statements due in April 2025, citing ongoing restructuring process -
COMMUNIQUÉ DE PRESSE
Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
Alzchem Group AG successfully completes long-term succession planning as Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer from January 1, 2026 -
COMMUNIQUÉ DE PRESSE
Secarna Pharmaceuticals to present new data and clinical strategy for lead antisense oligonucleotide program SECN-15 at ASCO 2025
Secarna Pharmaceuticals to present new data and clinical strategy for SECN-15 at ASCO 2025. Targeting NRP1 with antisense oligonucleotides for solid cancers. Promising therapeutic approach -
-
-
